For the first time worldwide, researchers have confirmed that the human heart possesses the capacity to regenerate muscle cells following a heart attack. Previously, this regenerative process had only been observed in mice, and this new finding challenges the long-held belief that damage to the cardiac muscle is irreversible, paving the way for the development of regenerative therapeutic strategies. The study, led by scientists from the University of Sydney, the Baird Institute, and the Royal Prince Alfred Hospital, reveals that the heart generates new muscle cells even after scar tissue has formed subsequent to a myocardial infarction. A heart attack can result in the demise of up to a third of the heart’s muscle cells. Despite advancements in patient survival rates, many individuals still develop heart failure, often necessitating an organ transplant. This novel discovery suggests the heart retains a degree of inherent self-renewal capability. The researchers concede that the extent of this regeneration is insufficient for complete functional restoration, but they believe it can be augmented in the future to enhance patient recovery trajectories. Dr. Robert Hume elaborated: “Up until now, our assumption was that because heart cells perish after a heart attack, those regions of the heart suffer permanent damage, leading to reduced blood pumping efficiency to the body’s organs. Our investigation demonstrates that, even with residual scarring post-infarction, the heart is manufacturing new muscle cells, which opens up fresh avenues.” The research validates that cardiomyocyte mitosis, the division of heart muscle cells, occurs in humans following a heart attack. This cellular activity was previously only documented in animal models. The scientists examined tissue samples procured from living patients undergoing bypass surgery. These samples, taken from both healthy and compromised cardiac regions, supplied direct evidence of cell regeneration. The ability to study live human heart tissue proved pivotal to this breakthrough. The researchers employed a sampling methodology devised for use during surgery, enabling real-time observation of cellular processes. Professor Shaun Lal stated: “Ultimately, the objective is to leverage this insight to engineer novel cardiac cells capable of reversing heart failure. By utilizing actual live human heart tissue models in our work, we ensure that the data informing the development of new cardiovascular treatments is more precise and dependable.” The research team contends that this methodology establishes a robust testing platform for emergent regenerative therapies. Initial findings have already pointed to the presence of proteins linked to cardiac regeneration in the animal model studies, offering clues for future human therapy design. Cardiovascular disease remains the leading global cause of death, accounting for approximately 24 percent of fatalities in Australia. Considering that around 144,000 Australians live with heart failure, and only about 115 transplants are performed annually, there is an urgent requirement for alternative treatment modalities. The researchers suggest this discovery could fundamentally alter perceptions of heart damage, shifting focus from permanent loss to limited biological repair. While the body’s regenerative response is modest, it implies that the human heart retains a previously underestimated potential for self-repair. Subsequent work will concentrate on boosting the heart’s intrinsic capacity for cell regeneration. Should this endeavor prove successful, it could decrease the reliance on transplants and improve long-term outcomes for patients who have experienced a heart attack.
About the Author
